Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-04-26Clinical Trial Update: Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy
A retrospective study in metastatic renal cell carcinoma evaluating the efficacy and safety of targeted therapies after Pazopanib as first-l…
-
CLINICAL_TRIALS trial_result · 2018-04-19Clinical Trial Update: Safety Study of SGN-CD70A in Cancer Patients [Phase 1]
A Phase 1 safety study of SGN-CD70A in renal cell carcinoma and several lymphomas has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma
The clinical trial update reports on plasma glycosaminoglycans as diagnostic and prognostic biomarkers in patients who have undergone surger…
-
CLINICAL_TRIALS trial_result · 2018-04-04Clinical Trial Update: Pilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of Biomarkers [NA]
A completed pilot study evaluating neoadjuvant everolimus for advanced renal cell carcinoma, including biomarker analyses.
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: Third Line TKI After 2 TKIs in Patients With mRCC (Tokio Study) [Phase 2]
Phase 2 clinical trial (Tokio Study) evaluating a third-line tyrosine kinase inhibitor after two prior TKIs in metastatic renal cell carcino…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-03-01Clinical Trial Update: A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer [Phase 2]
A Phase II trial of perifosine following tyrosine kinase inhibitor failure in renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-14Clinical Trial Update: A Comparative Study Between AirSeal, an Integrated Insufflation System, and Conventional Insufflation [NA]
A completed clinical trial comparing AirSeal integrated insufflation system with conventional insufflation for renal cell carcinoma; results…
-
CLINICAL_TRIALS trial_result · 2018-02-05Clinical Trial Update: Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE) [Phase 4]
A Phase 4 clinical trial assessing outcome-related factors in patients with metastatic renal cell carcinoma treated with everolimus has been…
-
CLINICAL_TRIALS trial_result · 2017-12-29Clinical Trial Update: Phase II Study of Anlotinib in Patients With Advanced Renal Cell Carcinoma That Have Failed Or Are Intolerant To TKIs Therapy [Phase 2]
Phase II study evaluating Anlotinib in patients with advanced renal cell carcinoma after TKI therapy failure or intolerance.
-
CLINICAL_TRIALS trial_result · 2017-12-21Clinical Trial Update: A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) as Monotherapy or in Combination With Bevacizumab (Avastin®) Compared to Sunitinib (Sutent®) in Participants With Untreated Advanced Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating atezolizumab alone or with bevacizumab vs sunitinib in untreated advanced renal cell carcinoma; results posted in 2…
-
CLINICAL_TRIALS trial_result · 2017-12-20Clinical Trial Update: Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating Avastin and Temsirolimus after tyrosine kinase inhibitor failure in advanced renal cell carcinoma has completed wit…
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients With Cancer and Amyotrophic Lateral Sclerosis
A completed study examining the feasibility of using a consumer-based accelerometer to monitor outpatient physical activity in patients with…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer
A completed clinical trial evaluated anti-IMP3 autoantibody and microRNA signature blood tests for detecting metastasis in patients with loc…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial evaluating the combination of bortezomib and cetuximab in patients with advanced solid tumors across multiple cancer types; …
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer [Phase 1, Phase 2]
A Phase 1/2 trial update on using combination chemotherapy and total-body irradiation before donor umbilical cord blood transplant in patien…
-
CLINICAL_TRIALS trial_result · 2017-11-28Clinical Trial Update: Study on the Influence of Sunitinib and Sorafenib on Fatigue, QoL, Depression in Patients With Metastatic RCC or GIST
A completed clinical trial evaluated the impact of sunitinib and sorafenib on fatigue, quality of life, and depression in patients with meta…
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: Second Line Sorafenib After Pazopanib in Patients With RCC [Phase 2]
A Phase 2 trial evaluating second-line sorafenib after prior pazopanib in metastatic renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients [Phase 1]
Phase 1 study evaluating the safety and tolerability of GW786034 in combination with lapatinib in cancer patients, including those with rena…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: A Two-way Crossover Study Of The Effect Of Food On The Pharmacokinetics Of Pazopanib In Cancer Patients [Phase 1]
A Phase 1 two-way crossover study assessed the effect of food on the pharmacokinetics of Pazopanib in cancer patients to inform dosing consi…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034 [Phase 1]
Phase 1 clinical trial update for GW786034 in renal cell carcinoma, with Part A radiolabel study and Part B single-dose evaluation. The stud…
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: VEG111485: A QTc Study of Pazopanib [Phase 1]
This update covers the completion of a Phase 1 QTc study evaluating pazopanib in renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: Oral Topotecan As A Radiosensitizing Agent In Rectal Cancer [Phase 1]
Phase 1 trial evaluating oral topotecan as a radiosensitizing agent in rectal cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2) [Phase 4]
Open-label, single-arm Phase 4 trial evaluating everolimus in patients with metastatic renal cell carcinoma after failure of the first VEGF-…
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Caphosol in Oral Mucositis Due to Targeted Therapy [Phase 3]
A Phase 3 trial evaluating Caphosol for oral mucositis caused by targeted cancer therapies has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Phase I Study of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors [Phase 1]
Phase I trial evaluating Pazopanib alone and in combination with Lapatinib in Japanese patients with solid tumors, including renal cell carc…